Leonteq Securities AG bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 36,408 shares of the company’s stock, valued at approximately $731,000.
Other institutional investors also recently made changes to their positions in the company. Geneos Wealth Management Inc. grew its holdings in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Danske Bank A S bought a new position in shares of Bath & Body Works during the third quarter valued at approximately $39,000. Activest Wealth Management bought a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $32,000. Advisory Services Network LLC bought a new position in shares of Bath & Body Works during the third quarter valued at approximately $48,000. Finally, Westfuller Advisors LLC bought a new position in shares of Bath & Body Works during the third quarter valued at approximately $56,000. 95.14% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on BBWI. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a report on Monday, April 20th. Telsey Advisory Group increased their price objective on Bath & Body Works from $23.00 to $25.00 and gave the stock a “market perform” rating in a report on Thursday, March 5th. TD Cowen decreased their price objective on Bath & Body Works from $26.00 to $20.00 and set a “buy” rating for the company in a report on Monday. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and increased their price objective for the stock from $21.00 to $25.00 in a report on Tuesday, February 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $21.21.
Bath & Body Works Price Performance
Shares of BBWI stock opened at $17.74 on Friday. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $33.96. The firm has a market capitalization of $3.57 billion, a price-to-earnings ratio of 5.63, a price-to-earnings-growth ratio of 1.72 and a beta of 1.43. The business has a 50 day simple moving average of $18.72 and a 200 day simple moving average of $20.37.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.28. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.59 billion. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The business’s revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period in the prior year, the company posted $2.09 EPS. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts anticipate that Bath & Body Works, Inc. will post 2.61 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio is 25.40%.
About Bath & Body Works
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
